EP2494351 - COLON AND RECTAL TUMOR MARKERS AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.04.2017 Database last updated on 03.09.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Externautics S.p.A. Via Fiorentina, 1 53100 Siena / IT | [2012/36] | Inventor(s) | 01 /
GRIFANTINI, Renata c/o Externautics S.P.A Via Fiorentina 1 53100 Siena / IT | 02 /
PILERI, Piero c/o Externautics S.P.A. Via Fiorentina 1 53100 Siena / IT | 03 /
CAMPAGNOLI, Susanna c/o Externautics S.P.A. Via Fiorentina 1 53100 Siena / IT | 04 /
GRANDI, Alberto c/o Externautics S.P.A. Via Fiorentina 1 53100 Siena / IT | 05 /
PARRI, Matteo c/o Externautics S.P.A. Via Fiorentina 1 53100 Siena / IT | 06 /
PIERLEONI, Andrea c/o Externautics S.P.A. Via Fiorentina 1 53100 Siena / IT | 07 /
NOGAROTTO, Renzo c/o Externautics S.P.A. Via Fiorentina 1 53100 Siena / IT | [2012/36] | Representative(s) | Banfi, Paolo Bianchetti & Minoja with Trevisan & Cuonzo IPS Srl Via Plinio, 63 20129 Milano / IT | [N/P] |
Former [2016/23] | Banfi, Paolo Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | ||
Former [2012/36] | Banfi, Paolo Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | Application number, filing date | 10778592.5 | 26.10.2010 | [2016/23] | WO2010EP66144 | Priority number, date | EP20090174059 | 26.10.2009 Original published format: EP 09174059 | [2012/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011051276 | Date: | 05.05.2011 | Language: | EN | [2011/18] | Type: | A1 Application with search report | No.: | EP2494351 | Date: | 05.09.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.05.2011 takes the place of the publication of the European patent application. | [2012/36] | Type: | B1 Patent specification | No.: | EP2494351 | Date: | 08.06.2016 | Language: | EN | [2016/23] | Search report(s) | International search report - published on: | EP | 05.05.2011 | Classification | IPC: | G01N33/50, G01N33/574 | [2012/36] | CPC: |
G01N33/57419 (EP,US);
G01N2500/10 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/36] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | KOLON- UND REKTALTUMORMARKER SOWIE VERFAHREN ZU IHRER VERWENDUNG | [2012/36] | English: | COLON AND RECTAL TUMOR MARKERS AND METHODS OF USE THEREOF | [2012/36] | French: | MARQUEURS DE TUMEURS DU RECTUM ET DU CÔLON, ET LEURS MÉTHODES D'UTILISATION | [2012/36] | Entry into regional phase | 22.05.2012 | National basic fee paid | 22.05.2012 | Designation fee(s) paid | 22.05.2012 | Examination fee paid | Examination procedure | 22.05.2012 | Examination requested [2012/36] | 20.12.2012 | Amendment by applicant (claims and/or description) | 25.07.2013 | Despatch of a communication from the examining division (Time limit: M04) | 27.11.2013 | Reply to a communication from the examining division | 10.04.2014 | Despatch of a communication from the examining division (Time limit: M06) | 10.10.2014 | Reply to a communication from the examining division | 15.05.2015 | Communication of intention to grant the patent | 08.09.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.09.2015 | Communication of intention to grant the patent | 14.01.2016 | Fee for grant paid | 14.01.2016 | Fee for publishing/printing paid | 14.01.2016 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.07.2013 | Opposition(s) | 09.03.2017 | No opposition filed within time limit [2017/20] | Fees paid | Renewal fee | 29.10.2012 | Renewal fee patent year 03 | 28.10.2013 | Renewal fee patent year 04 | 27.10.2014 | Renewal fee patent year 05 | 28.04.2016 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.10.2015 | 06   M06   Fee paid on   28.04.2016 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 26.10.2010 | AL | 08.06.2016 | AT | 08.06.2016 | BE | 08.06.2016 | BG | 08.06.2016 | CY | 08.06.2016 | CZ | 08.06.2016 | DK | 08.06.2016 | EE | 08.06.2016 | ES | 08.06.2016 | FI | 08.06.2016 | HR | 08.06.2016 | LT | 08.06.2016 | LV | 08.06.2016 | MC | 08.06.2016 | MK | 08.06.2016 | NL | 08.06.2016 | PL | 08.06.2016 | RO | 08.06.2016 | RS | 08.06.2016 | SE | 08.06.2016 | SI | 08.06.2016 | SK | 08.06.2016 | SM | 08.06.2016 | TR | 08.06.2016 | NO | 08.09.2016 | GR | 09.09.2016 | IS | 08.10.2016 | PT | 10.10.2016 | IE | 26.10.2016 | LU | 26.10.2016 | CH | 31.10.2016 | LI | 31.10.2016 | MT | 31.10.2016 | [2018/46] |
Former [2018/38] | HU | 26.10.2010 | |
AT | 08.06.2016 | ||
BE | 08.06.2016 | ||
BG | 08.06.2016 | ||
CY | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
HR | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
MC | 08.06.2016 | ||
MK | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
TR | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
IE | 26.10.2016 | ||
LU | 26.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
MT | 31.10.2016 | ||
Former [2018/32] | HU | 26.10.2010 | |
AT | 08.06.2016 | ||
BE | 08.06.2016 | ||
CY | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
HR | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
MC | 08.06.2016 | ||
MK | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
TR | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
IE | 26.10.2016 | ||
LU | 26.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
MT | 31.10.2016 | ||
Former [2018/29] | HU | 26.10.2010 | |
AT | 08.06.2016 | ||
BE | 08.06.2016 | ||
CY | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
HR | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
MC | 08.06.2016 | ||
MK | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
TR | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
IE | 26.10.2016 | ||
LU | 26.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
Former [2018/28] | HU | 26.10.2010 | |
AT | 08.06.2016 | ||
BE | 08.06.2016 | ||
CY | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
HR | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
MC | 08.06.2016 | ||
MK | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
IE | 26.10.2016 | ||
LU | 26.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
Former [2017/51] | AT | 08.06.2016 | |
BE | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
IE | 26.10.2016 | ||
LU | 26.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
Former [2017/43] | AT | 08.06.2016 | |
BE | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
LU | 26.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
Former [2017/37] | AT | 08.06.2016 | |
BE | 08.06.2016 | ||
CZ | 08.06.2016 | ||
DK | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SI | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
CH | 31.10.2016 | ||
LI | 31.10.2016 | ||
Former [2017/11] | AT | 08.06.2016 | |
BE | 08.06.2016 | ||
CZ | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SK | 08.06.2016 | ||
SM | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
PT | 10.10.2016 | ||
Former [2017/10] | BE | 08.06.2016 | |
CZ | 08.06.2016 | ||
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
PL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
SK | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
IS | 08.10.2016 | ||
Former [2017/09] | CZ | 08.06.2016 | |
EE | 08.06.2016 | ||
ES | 08.06.2016 | ||
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
RO | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
Former [2016/52] | ES | 08.06.2016 | |
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
RS | 08.06.2016 | ||
SE | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
Former [2016/51] | ES | 08.06.2016 | |
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
RS | 08.06.2016 | ||
NO | 08.09.2016 | ||
GR | 09.09.2016 | ||
Former [2016/50] | ES | 08.06.2016 | |
FI | 08.06.2016 | ||
LT | 08.06.2016 | ||
LV | 08.06.2016 | ||
NL | 08.06.2016 | ||
RS | 08.06.2016 | ||
NO | 08.09.2016 | ||
Former [2016/49] | FI | 08.06.2016 | |
LT | 08.06.2016 | ||
NL | 08.06.2016 | ||
NO | 08.09.2016 | ||
Former [2016/46] | LT | 08.06.2016 | |
NO | 08.09.2016 | Cited in | International search | [X]WO9932639 (REGENERON PHARMA [US]) [X] 1 * AR-1 = ANGPTL7;;; figure 4; claim - *; | [X]EP1696029 (GENENTECH INC [US]) [X] 1-6* SEQ ID NO: 19= NL4 = ANGPTL7;; paragraphs [0189] , [0192] , [0194] , [0243] , [0250]; claim - *; | [X]US2007237770 (LAI ALBERT [US], et al) [X] 1-6 * SLC39A10; page 76, paragraph 26; claim - *; | [A]WO2008004719 (ORIENTBIO CO LTD [KR], et al) [A] 1-6 * page 6, line 15; claim - * * page 11, line 2 - page 12, line 3 *; | [A] - AUSCH C ET AL, "Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients", EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, LONDON, GB, vol. 35, no. 11, doi:DOI:10.1016/J.EJSO.2009.02.007, ISSN 0748-7983, (20090228), pages 1164 - 1168, (20090228), XP026681636 [A] 1-11 * abstract * DOI: http://dx.doi.org/10.1016/j.ejso.2009.02.007 | by applicant | JP2002360254 | US2003064439 | EP1498424 | WO2005030250 | US7045603 | US7129325 | US7166703 | US7189806 | US2007154889 | US7244816 | US2007237770 | US7309762 | US7329404 | US7343721 | US7368531 | WO2008065544 | US2008280779 | - ADAMS G.P.; WEINER L.M., "Monoclonal antibody therapy cancer", NAT BIOTECHNOL., (2005), vol. 23, pages 1147 - 57 | - KOHLER; MILSTEIN, NATURE, (1975), vol. 265, page 495 | - NUCLEIC ACIDS RES., (19901025), vol. 18, no. 20, pages 6069 - 6074 | - KONONEN J ET AL., NATURE MED., (1998), vol. 4, pages 844 - 847 | - KALLIONIEMI OP, HUM. MOL. GENET., (2001), vol. 10, pages 657 - 662 | - KAMPF C. ET AL., CLIN. PROTEOMICS, (2004), vol. 1, pages 285 - 300 | - ANDERSON, L.; SEILHAMER, J., "A comparison of selected mRNA and protein abundances in human liver", ELECTROPHORESIS, (1997), vol. 18, pages 533 - 537 | - CHEN, G.; GHARIB, T. G.; WANG, H.; HUANG, C. C.; KUICK, R.; THOMAS, D. G.; SHEDDEN, K. A.; MISEK, D. E.; TAYLOR, J. M.; GIORDANO,, "Protein profiles associated with survival in lung adenocarcinoma.", PROC. NATL. ACAD. SCI. U. S. A, (2003), vol. 100, pages 13537 - 13542 | - GINESTIER, C.; CHARAFE-JAUFFRET, E.; BERTUCCI, F.; EISINGER, F.; GENEIX, J.; BECHLIAN, D.; CONTE, N.; ADELAIDE, J.; TOIRON, Y.; NG, "Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers", AM. J. PATHOL., (2002), vol. 161, pages 1223 - 1233 | - GYGI, S. P.; ROCHON, Y.; FRANZA, B. R.; AEBERSOLD, R., "Correlation between protein and mRNA abundance in yeast", MOL. CELL. BIOL., (1999), vol. 19, pages 1720 - 1730 | - NISHIZUKA, S.; CHARBONEAU, L.; YOUNG, L.; MAJOR, S.; REINHOLD, W. C.; WALTHAM, M.; KOUROS-MEHR, H.; BUSSEY, K. J.; LEE, J. K.; ESP, "Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays", PROC. NATL. ACAD. SCI. U. S. A, (2003), vol. 100, pages 14229 - 14234 | - TYERS, M.; MANN, M., "genomics to proteomics", NATURE, (2003), vol. 422, pages 193 - 197 | - BOUIS D; HOSPERS GA; MEIJER C; DAM W; PEEK R; MULDER NH., "Effects of the CDT6/ANGX gene on tumour growth in immune competent mice, In Vivo", EFFECTS OF THE CDT6/ANGX GENE ON TUMOUR GROWTH IN IMMUNE COMPETENT MICE, IN VIVO, (2003), vol. 17, pages 157 - 61 | - BOUIS DR; DAM WA; MEIJER C; MULDER NH; HOSPERS GA., "Effect of CDT6 on factors of angiogenic balance in tumour cell lines", ANTICANCER RES., vol. 27, pages 2325 - 2329 | - PEEK R; KAMMERER RA; FRANK S; OTTE-HOLLER I; WESTPHAL JR., "The angiopoietin-like factor cornea-derived transcript 6 is a putative morphogen for human cornea.", J BIOL CHEM, (2002), vol. 277, pages 686 - 693 | - NGUYEN ST; HASEGAWA S; TSUDA H; TOMIOKA H; USHIJIMA M; NODA M; OMURA K; MIKI Y, "Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma.", CANCER SCI., (2007), vol. 98, pages 740 - 746 | - KAGARA N; TANAKA N; NOGUCHI S; HIRANO T., "Zinc and its transporter ZIP 10 are involved in invasive behavior of breast cancer cells", CANCER SCI., (2007), vol. 98, pages 692 - 697 | - KASPER G; WEISER AA; RUMP A; SPARBIER K; DAHL E; HARTMANN A; WILD P; SCHWIDETZKY U; CASTANOS-VELEZ E; LEHMANN K., "Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients", INT J CANCER., (2005), vol. 117, pages 961 - 973 | - HUANG X; GODFREY TE; GOODING WE; MCCARTY KS JR; GOLLIN SM, GENES CHROMOSOMES CANCER, (2006), vol. 45, pages 1058 - 69 | - CANCER, vol. 45, pages 1058 - 1069 | - WAN, B.; ZHOU, Y.B.; ZHANG, X.; ZHU, H.; HUO, K.; HAN, Z.G., "hOLFMLl, a novel secreted glycoprotein, enhances the proliferation", HUMAN CANCER CELL LINES IN VITRO FEBS LETT., (2008), vol. 582, pages 3185 - 3192 | - SLADEK R; ROCHELEAU G; RUNG J; DINA C; SHEN L; SERRE D; BOUTIN P; VINCENT D; BELISLE A; HADJADJ S, "A genome-wide association study identifies novel risk loci for type 2 diabetes", NATURE, (2007), vol. 445, pages 881 - 885 | US20060432604 |